Device Trial Radar · NCT07258069
Study On Histoacryl Used For Embolization Of Middle Meningeal Artery (MMA) In Chronic Subdural Hematoma (CSDH)
Last checked: Nov 19, 2026Latest source record: Oct 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
178
Planned (sponsor's estimate)
Start
Apr 10, 2026
Primary completion
Dec 2026
Study completion Aug 2027
Sponsor
- Lead sponsor
- Aesculap AGNot on our public-company list
- Sponsor type
- Industry
- First posted
- Dec 2, 2025
Design
- Study type
- Observational
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The aim of the study is to proof the effectiveness of Histoacryl® on preventing recurrence or progression of subdural hematoma after embolization of the middle meningeal artery.
Conditions
- Subdural Hematoma
- Subdural Hematoma, Chronic
Interventions
Histoacryl®Device
Histoacryl® is used by direct needle puncture, transcatheter approach, or transendoscopic approach in vascular embolization for the described purposes.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Recurrence or progression of subdural hematomaTime frame: within 3 months
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
Kokura Memorial Hospital
Fukuoka, Kitakyushu-city, Japan · Not yet recruiting
Ohara HealthCare Foundation Kurashiki Central Hospital
Okayama, Kurashiki, Japan · Not yet recruiting
Shimizu Hospital
Kyoto, Nishikyo-ku, Japan · Recruiting
3 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.